Assessing the chemical diversity of an hsp90 database

被引:23
作者
Audisio, Davide [1 ,2 ]
Messaoudi, Samir [1 ]
Ijjaali, Ismail [2 ]
Dubus, Elodie [2 ]
Petitet, Francois [2 ]
Peyrat, Jean-Francois [1 ]
Brion, Jean-Daniel [1 ]
Alami, Mouad [1 ]
机构
[1] Univ Paris Sud, CNRS, BioCIS UMR 8076, Lab Chim Therapeut,Fac Pharm, F-92296 Chatenay Malabry, France
[2] Aureus Pharma, F-75010 Paris, France
关键词
Heat shock protein 90; hsp90; inhibitors; Molecular descriptors; Chemical fragments; Chemical diversity; SMALL-MOLECULE INHIBITORS; SHOCK-PROTEIN; 90; COUPLING REACTION; ANTITUMOR AGENTS; NOVOBIOCIN; POTENT; HEAT-SHOCK-PROTEIN-90; DISCOVERY; BIOLOGY; SPACE;
D O I
10.1016/j.ejmech.2010.01.048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 90-kDa heat shock protein (hsp90) has emerged as a new, promising target for cancer drug discovery. With the simultaneous disruption of a large range of oncogenic pathways, hsp90 inhibition results in either cytostasis or cell death. Diverse inhibitors of this molecular chaperone are currently under intensive study, and several have reached clinical trials. In the present work, patented and published structure-activity relationships on hsp90 inhibitors were organised in a database format that associates chemical structures with their biological activities. This hsp90 database contains 814 unique structures and, to our knowledge, is the most complete ever reported. With the aim to provide a general overview and evaluation of the chemical diversity of the ligands included in the dataset, a two-dimensional analysis was performed. A set of twenty-five topological molecular descriptors was calculated, allowing the emphasis of those that have higher importance for hsp90 active compounds, and for the three chemical scaffold families, geldanamycins, purines and pyrazole-isoxazoles. We have used a principal-component analysis (PCA) computational approach to analyse the 2D descriptor space of active and non-active hsp90 ligands. Furthermore, a fragment-based study highlighted the most frequently moieties represented in the active purine and pyrazole-isoxazole derivatives that are likely to be responsible for the observed biological activities. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:2000 / 2009
页数:10
相关论文
共 37 条
[1]   A convenient and expeditious synthesis of 3-(N-substituted) aminocoumarins via palladium-catalyzed Buchwald-Hartwig coupling reaction [J].
Audisio, Davide ;
Messaoudi, Samir ;
Peyrat, Jean-Francois ;
Brion, Jean-Daniel ;
Alami, Mouad .
TETRAHEDRON LETTERS, 2007, 48 (39) :6928-6932
[2]   Heat Shock Protein 90 as a Drug Target: Some Like It Hot [J].
Banerji, Udai .
CLINICAL CANCER RESEARCH, 2009, 15 (01) :9-14
[3]   Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90 [J].
Barta, Thomas E. ;
Veal, James M. ;
Rice, John W. ;
Partridge, Jeffrey M. ;
Fadden, R. Patrick ;
Ma, Wei ;
Jenks, Matthew ;
Geng, Lifeng ;
Hanson, Gunnar J. ;
Huang, Kenneth H. ;
Barabasz, Amy F. ;
Foley, Briana E. ;
Otto, James ;
Hall, Steven E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) :3517-3521
[4]   Malnutrition could Predict 3-month Functional Prognosis in Mild Stroke Patients: Findings from a Nationwide Stroke Registry [J].
Qin, Haiqiang ;
Wang, Anxin ;
Zuo, Yingting ;
Zhang, Yaqing ;
Yang, Bo ;
Wei, Na ;
Zhang, Jing .
CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (05) :489-496
[5]   Synthesis of Hsp90 dimerization modulators [J].
Chiosis, Gabriela ;
Aguirre, Julia ;
Nicchitta, Christopher V. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) :3529-3532
[6]   Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90 [J].
Chiosis, Gabriela ;
Lucas, Brian ;
Huezo, Henri ;
Solit, David ;
Basso, Andrea ;
Rosen, Neal .
CURRENT CANCER DRUG TARGETS, 2003, 3 (05) :371-376
[7]   Chemical space and biology [J].
Dobson, CM .
NATURE, 2004, 432 (7019) :824-828
[8]   Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket [J].
Donnelly, Alison ;
Blagg, Brian S. J. .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (26) :2702-2717
[9]   Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design [J].
Dymock, BW ;
Barril, X ;
Brough, PA ;
Cansfield, JE ;
Massey, A ;
McDonald, E ;
Hubbard, RE ;
Surgenor, A ;
Roughley, SD ;
Webb, P ;
Workman, P ;
Wright, L ;
Drysdale, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4212-4215
[10]   Knowledge-based chemoinformatic approaches to drug discovery [J].
Ghose, Arup K. ;
Herbertz, Torsten ;
Salvino, Joseph M. ;
Mallamo, John P. .
DRUG DISCOVERY TODAY, 2006, 11 (23-24) :1107-1114